Washington University cardiologist at Barnes-Jewish Hospital, Daniel Lenihan, MD, presents a contemporary update of the diagnosis, epidemiology and current treatment available for cardiac amyloidosis. Several items are emphasized including the common noninvasive techniques to confirm the diagnosis and the utility of cardiac biopsy as part of the evaluation. Additionally, the latest clinical trials—particularly for novel new therapies for TTR amyloidosis—were highlighted.